A newly identified bird flu variant called genotype D1.1 swept across North America during the 2024 fall migration season, becoming the dominant strain in wild birds by December. Researchers tracking the virus found it in over 900 wildlife samples across Canada and the USA, spreading across all four major bird migration routes. While the rapid expansion is concerning, scientists say existing pandemic preparedness measures, including current vaccines, should remain effective against this new variant.

What Is Genotype D1.1 and Why Did It Spread So Fast?

Genotype D1.1 is a reassortant virus, meaning it formed when the highly pathogenic avian influenza A(H5N1) clade 2.3.4.4b virus, which arrived in North America in late 2021, mixed genetic material with local bird flu viruses already circulating on the continent. This genetic mixing created a new combination of gene segments that proved especially successful at spreading through wild bird populations.

The virus emerged around July 2024 in the northern Pacific flyway, likely originating in Alaska or western Canada, then rapidly dispersed southward and eastward throughout the continent. By December 2024, D1.1 had nearly replaced all previously circulating H5 variants, making it the predominant genotype across North America. This kind of rapid genetic sweep is not entirely new for bird flu viruses in the region, but the speed and completeness of D1.1's takeover was notable.

How Many People Have Been Infected, and How Severe Were the Cases?

As of the study's publication, 17 human cases of D1.1 infection had been reported, with 4 cases classified as severe or fatal. This represents a significant concern for public health officials, though the number remains relatively small compared to the millions of wild birds and hundreds of mammals affected. The human cases included infections in dairy cattle workers and other individuals with exposure to infected animals.

What makes these cases particularly important for researchers is understanding whether the virus is naturally acquiring the ability to spread more easily among mammals, or whether these infections represent isolated spillover events. The good news: genetic analysis of D1.1 viruses collected from wild birds showed they lacked the specific mutations that scientists associate with mammalian adaptation. This suggests the virus circulating in birds has not yet developed the genetic changes needed to spread efficiently between humans.

Ways to Understand the Current Risk Level

• Avian Receptor Preference: D1.1 viruses from wild birds showed strong binding to avian-like receptors in laboratory tests, with little to no affinity for human-like receptors, indicating the virus remains adapted to birds rather than humans.
• Absence of Mammalian Markers: None of the mammalian-adaptive mutations detected in human cases were found in wild bird viruses, suggesting human infections arose from direct exposure rather than from a virus that had already adapted to mammals.
• Vaccine Cross-Reactivity: Current candidate vaccine viruses retained moderate-to-high seroreactivity against D1.1 strains, meaning existing pandemic preparedness vaccines should provide protection if the virus were to spread more widely in humans.

Are Current Vaccines Still Effective Against D1.1?

Yes, according to the research. Scientists tested four current H5N1 candidate vaccine viruses against D1.1 and co-circulating strains. All viruses showed moderate-to-high cross-reactivity with at least one of the available vaccines, meaning the immune response generated by current vaccines should recognize and respond to D1.1 if exposure occurred.

This finding is crucial for pandemic preparedness. The World Health Organization maintains a library of candidate vaccine viruses specifically designed to respond quickly if a concerning bird flu variant begins spreading in humans. The fact that D1.1 remains antigenically similar to these existing vaccine candidates means public health authorities would not need to develop entirely new vaccines from scratch if the situation escalated.

What Does This Mean for the Average Person?

For most people, the risk of D1.1 infection remains very low. The virus is still primarily a bird disease, and human infections have occurred almost exclusively in people with direct contact to infected animals, such as poultry workers or dairy farmers. There is no evidence of human-to-human transmission of D1.1.

However, the emergence of D1.1 underscores why scientists continue to monitor bird flu viruses closely. Each new variant represents an opportunity for the virus to acquire mutations that could make it more dangerous to humans. The coordinated surveillance efforts across Canada and the USA that detected and tracked D1.1 are part of a broader pandemic preparedness strategy designed to catch concerning variants early, before they become widespread health threats.

For people working with poultry, dairy cattle, or wild birds, maintaining proper protective equipment and hygiene practices remains important. For the general public, the current risk from D1.1 is low, and existing vaccines would likely provide protection if the situation changed.